I'm optimistic about $MDAI's future, especially with its strong government support and upcoming catalysts that could significantly boost the share price. With a target of $3 by mid next year, it feels like a solid long-term investment given the company's current financial stability and potential growth prospects.

I believe Spectral AI ($MDAI) has massive upside potential due to its innovative DeepView AI technology, which significantly outperforms traditional methods in diagnosing burn wounds and diabetic foot ulcers. With upcoming commercialization and strong insider support, this stock could see substantial appreciation as it gains market recognition.